-
Gilead Agrees To Buy Kite Pharma, Leaping Into CAR-T Cancer Therapy
STAT | Gilead agrees to buy Kite Pharma and its emerging line of CAR-T oncology therapies, which aim to harnesses the immune system to fight cancer.
Aug 28, 2017
-
Allotrope Foundation: A Framework For Knowledge Management
Bio-IT World | 2017 Best Practices Awards | The Allotrope Foundation hopes their Allotrope Framework will allow researchers to rethink the way they acquire and manage scientific data.
Aug 25, 2017
-
The Next Digital Arms Race In Life Sciences
Bio-IT World Contributed Commentary | Life sciences research is in the middle of a digital arms race. As more research is conducted, more data is produced and more storage is required.
Aug 23, 2017
-
Data Sharing Built With BRICS
Bio-IT World | 2017 Best Practices Awards | The Biomedical Imaging Research Services Section of the NIH is offering its Biomedical Research Informatics Computing System to assist researchers in the collection and application of data for research studies and clinical trials.
Aug 21, 2017
-
Scientists Try Gene Editing In Human Embryos
NPR.org | Scientists at the Oregon Health & Science University have begun editing the DNA in human embryos to try to prevent genetic diseases.
Aug 18, 2017
-
Helix Teams Up With Illumina Accelerator To Drive Innovation And DNA-Powered Products
Bio-IT World Brief | Helix today announced a collaboration with Illumina Accelerator. Together, the organizations will partner with entrepreneurs to foster and accelerate innovation and development of DNA-driven products and insights for consumers.
Aug 17, 2017
-
Microsoft Acquires Cycle Computing Away From Amazon, Google
Business Insider | Microsoft's acquisition of Cycle will make its cloud business more attractive and give it access to a new group of customers.
Aug 16, 2017
-
Deep Learning Thrives In Cancer Moonshot
HPCwire | Recently, deep learning has emerged as a powerful tool in the arsenal in the Cancer Moonshot and is the driving force in the CANDLE project, a joint effort between the DOE and the NCI.
Aug 15, 2017
-
Your Genome May Become The Next Facebook
The Motley Fool | The social media king's targeted advertising made billions of dollars for investors. But something even bigger is on the horizon.
Aug 14, 2017


